| Issue Date | Title | Author(s) |
| 26-Feb-2021 | COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease | Katopodis, P; Kerslake, R; Davies, J; Randeva, HS; Chatha, K; Hall, M; Spandidos, DA; Anikin, V; Polychronis, A; Robertus, JL; Kyrou, I; Karteris, E |
| 2020 | Co‑expression of peripheral olfactory receptors with SARS‑CoV‑2 infection mediators: Potential implications beyond loss of smell as a COVID‑19 symptom | Kerslake, R; Hall, M; Randeva, H; Spandidos, D; Chatha, K; Kyrou, I; Karteris, E |
| 14-Oct-2020 | Is there a link between bisphenol A (BPA), a key endocrine disruptor, and the risk for SARS-CoV-2 infection and severe COVID-19? | Zahra, A; Sisu, C; Silva, E; De Aguiar Greca, S-C; Randeva, H; Chatha, K; Kyrou, I; Karteris, E |
| 15-Sep-2020 | Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19 | Davies, J; Randeva, HS; Chatha, K; Hall, M; Spandidos, DA; Karteris, E; Kyrou, I |
| 26-May-2020 | Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19 | Katopodis, P; Anikin, V; Randeva, H; Spandidos, D; Chatha, K; Kyrou, I; Karteris, E |
| 15-Jul-2020 | Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic | Kyrou, I; Karteris, E; Robbins, T; Chatha, K; Drenos, F; Randeva, HS |
